"The government did not give further details of the deal, saying they were commercially confidential, but said the agreement was in line with GSK's settlements with other countries. The British company, which is the biggest supplier of H1N1 vaccines, has already reached agreements to cut vaccine orders for Germany and Belgium."
So Germany & Belgium have reached similar deals, I wonder what other countries have had their vaccine replaced with Relenza? Will be an interesting quaterly report...
BTA Price at posting:
$2.26 Sentiment: Buy Disclosure: Held